Literature DB >> 12410249

Value drivers in licensing deals.

Katie Arnold1, Anthony Coia, Scott Saywell, Ty Smith, Scott Minick, Alicia Löffler.   

Abstract

Mesh：

Year:  2002        PMID： 12410249     DOI： 10.1038/nbt1102-1085

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  4 in total

1.  Why trash don't pass? pharmaceutical licensing and safety performance of drugs.

Authors:  Tannista Banerjee; Arnab Nayak
Journal:  Eur J Health Econ       Date:  2016-01-18

2.  Assessing the value-adding impact of diagnostic-type tests on drug development and marketing.

Authors:  Edward D Blair
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

3.  Valuation and Returns of Drug Development Companies: Lessons for Bioentrepreneurs and Investors.

Authors:  Daniel Tobias Michaeli; Hasan Basri Yagmur; Timur Achmadeev; Thomas Michaeli
Journal:  Ther Innov Regul Sci       Date:  2022-01-11       Impact factor: 1.778

4.  Value drivers of development stage biopharma companies.

Authors:  Daniel Tobias Michaeli; Hasan Basri Yagmur; Timur Achmadeev; Thomas Michaeli
Journal:  Eur J Health Econ       Date:  2022-01-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.